Bristol Myers Squibb Total Assets 2006-2021 | BMY

Bristol Myers Squibb total assets from 2006 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Bristol Myers Squibb total assets for the quarter ending September 30, 2021 were $110.893B, a 11.66% decline year-over-year.
  • Bristol Myers Squibb total assets for 2020 were $118.481B, a 8.82% decline from 2019.
  • Bristol Myers Squibb total assets for 2019 were $129.944B, a 271.42% increase from 2018.
  • Bristol Myers Squibb total assets for 2018 were $34.986B, a 4.28% increase from 2017.
Bristol Myers Squibb Annual Total Assets
(Millions of US $)
2020 $118,481
2019 $129,944
2018 $34,986
2017 $33,551
2016 $33,707
2015 $31,748
2014 $33,749
2013 $38,592
2012 $35,897
2011 $32,970
2010 $31,076
2009 $31,008
2008 $29,486
2007 $25,926
2006 $25,575
2005 $28,138
Bristol Myers Squibb Quarterly Total Assets
(Millions of US $)
2021-09-30 $110,893
2021-06-30 $110,797
2021-03-31 $112,435
2020-12-31 $118,481
2020-09-30 $125,536
2020-06-30 $128,076
2020-03-31 $129,285
2019-12-31 $129,944
2019-09-30 $57,433
2019-06-30 $55,163
2019-03-31 $34,834
2018-12-31 $34,986
2018-09-30 $33,734
2018-06-30 $32,641
2018-03-31 $33,083
2017-12-31 $33,551
2017-09-30 $33,977
2017-06-30 $33,409
2017-03-31 $32,937
2016-12-31 $33,707
2016-09-30 $33,727
2016-06-30 $32,831
2016-03-31 $31,892
2015-12-31 $31,748
2015-09-30 $31,779
2015-06-30 $31,954
2015-03-31 $33,579
2014-12-31 $33,749
2014-09-30 $33,450
2014-06-30 $33,503
2014-03-31 $33,424
2013-12-31 $38,592
2013-09-30 $36,804
2013-06-30 $36,252
2013-03-31 $35,958
2012-12-31 $35,897
2012-09-30 $36,044
2012-06-30 $31,667
2012-03-31 $32,408
2011-12-31 $32,970
2011-09-30 $32,014
2011-06-30 $31,833
2011-03-31 $30,851
2010-12-31 $31,076
2010-09-30 $31,885
2010-06-30 $31,051
2010-03-31 $30,753
2009-12-31 $31,008
2009-09-30 $30,951
2009-06-30 $29,809
2009-03-31 $29,693
2008-12-31 $29,486
2008-09-30 $28,476
2008-06-30 $28,064
2008-03-31 $26,325
2007-12-31 $25,926
2007-09-30 $26,098
2007-06-30 $27,175
2007-03-31 $26,091
2006-12-31 $25,575
2006-09-30 $27,215
2006-06-30 $27,402
2006-03-31 $27,461
2005-12-31 $28,138
2005-09-30 $25,609
2005-06-30 $25,233
2005-03-31 $28,407
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $141.036B $42.518B
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.
Stock Name Country Market Cap PE Ratio
Bio-Rad Laboratories (BIO.B) United States $17.472B 35.46
QIAGEN (QGEN) Netherlands $11.101B 18.80
Biohaven Pharmaceutical Holding (BHVN) United States $7.210B 0.00
Emergent Biosolutions (EBS) United States $2.527B 9.09
Arcus Biosciences (RCUS) United States $2.184B 0.00
Myovant Sciences (MYOV) United Kingdom $1.260B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.080B 0.00
Zymeworks (ZYME) Canada $0.522B 0.00
SQZ Biotechnologies (SQZ) United States $0.201B 0.00
Ambrx Biopharma (AMAM) United States $0.191B 0.00
Enzo Biochem (ENZ) United States $0.154B 19.81